Berkant Sönmez

449 total citations
10 papers, 237 citations indexed

About

Berkant Sönmez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Berkant Sönmez has authored 10 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Berkant Sönmez's work include Adipokines, Inflammation, and Metabolic Diseases (3 papers), Gastric Cancer Management and Outcomes (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Berkant Sönmez is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (3 papers), Gastric Cancer Management and Outcomes (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Berkant Sönmez collaborates with scholars based in Türkiye and United Kingdom. Berkant Sönmez's co-authors include Bala Başak Öven Ustaalıoğlu, Mesut Şeker, Mahmut Gümüş, Ahmet Bılıcı, Taflan Salepçi, Hülya Ilıksu Gözü, Emre Yıldırım, Umut Kefeli, Mehmet Karaduman and Mustafa Yaylacı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Medical Oncology.

In The Last Decade

Berkant Sönmez

10 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berkant Sönmez Türkiye 7 87 82 65 63 36 10 237
Ilenia Bartolini Italy 12 140 1.6× 153 1.9× 71 1.1× 67 1.1× 19 0.5× 30 317
Zefeng Shen China 11 152 1.7× 51 0.6× 66 1.0× 128 2.0× 10 0.3× 25 320
Mahyar Mohammadifard Iran 9 45 0.5× 46 0.6× 95 1.5× 32 0.5× 15 0.4× 33 221
Jessica L. Mueller United States 10 180 2.1× 30 0.4× 48 0.7× 53 0.8× 25 0.7× 31 343
Gianluca Mascianà Italy 11 178 2.0× 90 1.1× 55 0.8× 101 1.6× 14 0.4× 32 274
Sinan Akay Türkiye 9 112 1.3× 33 0.4× 104 1.6× 52 0.8× 9 0.3× 49 293
Masataka Hirabaru Japan 12 211 2.4× 151 1.8× 56 0.9× 90 1.4× 9 0.3× 26 325
John G. Aversa United States 11 63 0.7× 72 0.9× 25 0.4× 52 0.8× 14 0.4× 25 243
Francesco Serra Italy 9 141 1.6× 33 0.4× 27 0.4× 44 0.7× 14 0.4× 39 223
Kosuke Tanaka Japan 7 47 0.5× 32 0.4× 108 1.7× 22 0.3× 13 0.4× 26 227

Countries citing papers authored by Berkant Sönmez

Since Specialization
Citations

This map shows the geographic impact of Berkant Sönmez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berkant Sönmez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berkant Sönmez more than expected).

Fields of papers citing papers by Berkant Sönmez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berkant Sönmez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berkant Sönmez. The network helps show where Berkant Sönmez may publish in the future.

Co-authorship network of co-authors of Berkant Sönmez

This figure shows the co-authorship network connecting the top 25 collaborators of Berkant Sönmez. A scholar is included among the top collaborators of Berkant Sönmez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berkant Sönmez. Berkant Sönmez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sönmez, Berkant, et al.. (2016). Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer. SHILAP Revista de lepidopterología. 2(1). 12–15. 3 indexed citations
2.
Sönmez, Berkant. (2015). Oral Antidiyabetik İlaç Kullanan Tip 2 Diyabetes Mellitus Hastalarında Diyet ve Egzersizin Hemoglobin A1c Düzeylerine Etkisi. Konuralp Tıp Dergisi. 2015(2). 93–93. 1 indexed citations
3.
Şeker, Mesut, Ahmet Bılıcı, Bala Başak Öven Ustaalıoğlu, et al.. (2011). Hepatogastroenterology. Hepatogastroenterology. 58(110-111). 1841–6. 136 indexed citations
4.
Bılıcı, Ahmet, Bala Başak Öven Ustaalıoğlu, Mahmut Gümüş, et al.. (2010). Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?. Oncology Research and Treatment. 33(3). 101–105. 15 indexed citations
5.
Şeker, Mesut, Ahmet Bılıcı, Bala Başak Öven Ustaalıoğlu, et al.. (2010). Bilateral Conjunctival MALT Lymphoma Mimicking Chronic Conjunctivitis. Onkologie. 33(6). 317–320. 7 indexed citations
6.
Salepçi, Taflan, Mesut Şeker, Hüseyin Uyarel, et al.. (2009). 5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels. Medical Oncology. 27(2). 416–420. 29 indexed citations
7.
Şeker, Mesut, Hülya Ilıksu Gözü, Bala Başak Öven Ustaalıoğlu, et al.. (2009). Myasthenia Gravis and Autoimmune Addison Disease in a Patient With Thymoma. Clinical Lung Cancer. 10(5). 367–370. 9 indexed citations
8.
Şeker, Mesut, Ahmet Bılıcı, Berkant Sönmez, et al.. (2009). The association of serum adiponectin levels with histopathological variables in gastric cancer patients. Medical Oncology. 27(4). 1319–1323. 21 indexed citations
9.
Salman, Tarık, Ahmet Bılıcı, Bala Başak Öven Ustaalıoğlu, et al.. (2009). The correlation of thrombin-activated fibrinolysis inhibitor (TAFI) levels and clinicopathologic factors in advanced colorectal cancer patients. Journal of Clinical Oncology. 27(15_suppl). e22217–e22217. 1 indexed citations
10.
Aliustaoğlu, Mehmet, Ahmet Bılıcı, Mahmut Gümüş, et al.. (2009). Preoperative serum leptin levels in patients with breast cancer. Medical Oncology. 27(2). 388–391. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026